Journals / The Journal of Pediatric Research / 2020 / Cilt: 7 - Sayı: 3

Evaluation of the Relationship between Mucosal Diseases and Faecal Calprotectin Levels in Children who Underwent Upper Gastrointestinal System Endoscopy

Pages
185–191
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A positive correlation was discovered between eosinophil counts and FC levels in patients with H. pylorigastritis and esophagitis.Conclusion: The diagnostic value of FC levels in UGIS diseases was not sufficient to establish a definitive diagnosis in our study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, the correlation of faecal calprotectin (FC) levels with endoscopic and histopathological findings was evaluated in childrenwho underwent upper gastrointestinal system (UGIS) endoscopy.Materials and Methods: The patients aged 4-18 years admitted to our endoscopy unit were included in this study.
📊
Key Findings & Data:FC levels were compared with those of children with normal histopathology.Results: The FC levels of 112 children included in this study were evaluated according to their histopathological diagnoses.
💡
Conclusion & Impact:A positive correlation was discovered between eosinophil counts and FC levels in patients with H. pylorigastritis and esophagitis.Conclusion: The diagnostic value of FC levels in UGIS diseases was not sufficient to establish a definitive diagnosis in our study.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: In this study, the correlation of faecal calprotectin (FC) levels with endoscopic and histopathological findings was evaluated in childrenwho underwent upper gastrointestinal system (UGIS) endoscopy.Materials and Methods: The patients aged 4-18 years admitted to our endoscopy unit were included in this study. Faecal samples were collectedon the day participants presented for the study. A calprotectin assay was performed on the faecal samples using enzyme-linked immunosorbentassay kits. FC levels were compared with those of children with normal histopathology.Results: The FC levels of 112 children included in this study were evaluated according to their histopathological diagnoses. Their FC levels werenot found to be significantly higher than those in healthy children. No significant difference was found in the FC levels of participants with orwithout signs of inflammation in the esophagus, stomach and duodenum. In those participants with chronic gastritis, Helicobacter pylori (H.pylori) gastritis, reflux esophagitis or celiac disease, FC levels above cut-off values were observed. However, no significant difference was foundin those participants with normal endoscopic findings. There was no significant difference in FC levels between similar regions of the UGISwith or without signs of inflammation. A positive correlation was discovered between eosinophil counts and FC levels in patients with H. pylorigastritis and esophagitis.Conclusion: The diagnostic value of FC levels in UGIS diseases was not sufficient to establish a definitive diagnosis in our study.

🔖

Cite This Article

BARAN, M., APPAK, Y. Ç., ARSLAN, F. D., SOLAKOĞLU, D., KARAKOYUN, M., KARAKOYUN, İ., EMİR, B., DİNİZ, G. (2020). Evaluation of the Relationship between Mucosal Diseases and Faecal Calprotectin Levels in Children who Underwent Upper Gastrointestinal System Endoscopy. The Journal of Pediatric Research, Cilt: 7 - Sayı: 3, 185–191. https://ajindex.com/articles/363000

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, et al. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study. Ann Fam Med 2016; 14:437-45
  2. Waugh N, Cummins E, Royle P, et al. Faecal calprotectin testing for differentiating amongst inflammatory and noninflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess 2013; 17:xv-xix, 1-211
  3. Kanik A, Baran M, Ince FD, et al. Faecal calprotectin levels in children with Henoch-Schönlein purpura: is this a new marker for gastrointestinal involvement? Eur J Gastroenterol Hepatol 2015; 27:254-8
  4. Biskou O, Gardner-Medwin J, Mackinder M, et al. Faecal Calprotectin in Treated and Untreated Children With Coeliac Disease and Juvenile Idiopathic Arthritis. J Pediatr Gastroenterol Nutr 2016; 63:e112-5
  5. Balamtekin N, Baysoy G, Uslu N, et al. Fecal calprotectin concentration is increased in children with celiac disease: relation with histopathological findings. Turk J Gastroenterol 2012; 23:503-8
  6. Ertekin V, Selimoğlu MA, Turgut A, Bakan N. Fecal calprotectin concentration in celiac disease. J Clin Gastroenterol 2010; 44:544-6
  7. Siddiqui I, Majid H, Abid S. Update on clinical and research application of fecal biomarkers for gastrointestinal diseases. World J Gastrointest Pharmacol Ther 2017; 8:39-46
  8. Fagerberg UL, Lööf L, Myrdal U, Hansson LO, Finkel Y. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 2005; 40:450-5
  9. Hassan TMM, Al-Najjar SI, Al-Zahrani IH, Alanazi FIB, Alotibi MG. Helicobacter pylori chronic gastritis updated Sydney grading in relation to endoscopic findings and H. pylori IgG antibody: diagnostic methods. J Microsc Ultrastruct 2016; 4:167- 74
  10. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996; 20:1161-81
  11. Dixon MF, Genta RM, Yardley JH, Correa P. Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter 1997; 2:17-24
  12. Posten S, Adamiak T, Jensen M. Pediatric Eosinophilic Esophagitis. S D Med 2018; 71:362-6
  13. Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterolo